• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Enforcement Report - Week of April 24, 2013

  • Print
  • Share
  • E-mail
-

Product Detail

Product Description Suprax (cefixime for oral suspension) USP, 100 mg/5 mL, 50 mL bottles (when reconstituted), Manufactured for Lupin Pharmaceuticals, Inc. 111 South Calvert Street, Baltimore, MD 21202, Manufactured by Lupin Limited Mumbai 400 058 India, NDC 68180-202-03.
Recall Number D-264-2013
Classification Class III
Code Info Lot #s: MSA 2021A, MSA 2024A, MSA 2025A, Exp July 2014
Product Distributed Qty 64,368 bottles
Reason For Recall Discoloration; Product may not meet specifications for color description once reconstituted.

Event Detail

Event Id 64325
Product Type Drugs
Status Ongoing
Recalling Firm Lupin Pharmaceuticals Inc.
City Baltimore
State MD
Country US
Voluntary / Mandated Voluntary: Firm Initiated
Recall Initiation Date 2013-01-31
Initial Firm Notification of Consignee or Public Letter
Distribution Pattern Nationwide
-
-